President Archives - European Industrial Pharmacists Group (EIPG)

Home  /  General Assembly 2022: Bureau elections  /  President

ECA’s guide to compliant equipment design


By Giuliana Miglierini The legislative evolution of the last decades emphasised requirements for equipment used in pharmaceutical productions. This is even more true with the entry into force of the new Annex 1 to the GMPs, characterised by many new Read more

Webinar: ICH Q12 Product Lifecycle Management – open road or dead end?


Next EIPG webinar is to be held on Tuesday 18th April 2023 at 17.00 CEST (16.00 BST) in conjunction with PIER and University College Cork. Graham Cook, former Pfizer’s Quality Intelligence and Compliance Information team leader and chair of Read more

Draft ICH M13A guideline on bioequivalence open for consultation


By Giuliana Miglierini The draft ICH M13A harmonised guideline “Bioequivalence for immediate-release solid oral dosage forms” was endorsed by the International Council for Harmonisation on 20 December 2022 and is now open for consultation. Comments can be forwarded until 26 Read more

•••

General Assembly 2022: Bureau elections

October 24, 2022 , , , , , ,

At the General Assembly held on October 15-16 in Athens, voting took place for the positions of EIPG President and Vice-President of Technical and Professional Development.

The delegates present at this annual meeting elected Piero Iamartino as President for the next three-year mandate. Rebecca Stanbrook was elected to the position of Vice-President of Technical and Professional Development. Brigitte Saunier completed her term of office as Treasurer and was thanked for her valuable support. Maurizio Battistini, Vice-President of European Affairs will act as EIPG Treasurer until the next General Assembly.

Claude Farrugia who has been President for two mandates and previously Vice -President of Communications was warmly thanked for his significant contribution to the progress EIPG has made in recent years as a reputable professional association recognised by the European Health Authorities.

The new President together with the current Vice-Presidents highlighted their main strategic objectives confirming their full commitment to developing and promoting the position of the industrial pharmacist in Europe.